Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Giby V. George"'
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 1063-1067 (2024)
Abstract The clinical manifestations and pathophysiology of clonal hematopoiesis (CH)‐associated immunological dysfunction are poorly understood. We describe an elderly woman with CH who developed various systemic inflammatory or autoimmune disease
Externí odkaz:
https://doaj.org/article/e0b96a8866bc497fa40e4cbf851554dc
Autor:
Giby V. George, Diana G. Aldowitz, Audrey N. Jajosky, Danielle S. Wallace, W. Richard Burack, Jonathan W. Friedberg, Siba El Hussein
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 599-602 (2024)
Abstract Primary large B‐cell lymphomas of immune‐privileged sites (IP‐LBCLs) comprise LBCLs arising within “immune sanctuaries,” including the central nervous system (CNS), vitreoretina, and testes. Although patients present with localized
Externí odkaz:
https://doaj.org/article/58d783c3b450425c8cc31e067701e3ab
Autor:
Mayur Narkhede, Sarah Tomassetti, Madiha Iqbal, Antony Tin, Samuel Rivero-Hinojosa, Giby V. George, Hayley Widden, Ryan Benrud, Meenakshi Malhotra, Angel Rodriguez, Minetta C. Liu
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundA novel approach for molecular residual disease (MRD) detection and treatment monitoring is needed in diffuse large B-cell lymphoma (DLBCL) to identify patients with a poor prognosis. We performed a retrospective evaluation of commercial ct
Externí odkaz:
https://doaj.org/article/275a98f96b254ebebbd094c8182d6f4f
Autor:
Brandon M. Huffman, Vasily N. Aushev, Griffin L. Budde, Joseph Chao, Farshid Dayyani, Diana Hanna, Gregory P. Botta, Daniel V.T. Catenacci, Steven B. Maron, Shifra Krinshpun, Shruti Sharma, Giby V. George, Meenakshi Malhotra, Adham Jurdi, Solomon Moshkevich, Alexey Aleshin, Pashtoon M. Kasi, Samuel J. Klempner
Publikováno v:
JCO Precision Oncology.
PURPOSE Circulating tumor DNA (ctDNA) analyses allow for postoperative risk stratification in patients with curatively treated colon and breast cancers. Use of ctDNA in esophagogastric cancers (EGC) is less characterized and could identify high-risk
Autor:
Marcia M. Russell, Mina S. Sedrak, Dominic Moon, Giby V. George, Genevieve Hollis, Martine Extermann, Fareeha Siddiqui, Sumi Misra, Amy L. Stella, Katherine Clifton, Ishwaria Mohan Subbiah, Louise C. Walter, William P. Tew, Liz Hollinger, Elizabeth R. Kessler, Reshma Jagsi, Grant R. Williams, Thuy T. Koll, Ilene S. Browner, Derek L. Stirewalt, Beatriz Korc-Grodzicki, Harvey J. Cohen, Sumati Gupta, Efrat Dotan, Cynthia Owusu, Hema Sundar, June M. McKoy, Joleen M. Hubbard, Ashley E. Rosko, Nancy L. Keating, Tracey O'Connor, Cary P. Gross
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:1006-1019
The NCCN Guidelines for Older Adult Oncology address specific issues related to the management of cancer in older adults, including screening and comprehensive geriatric assessment (CGA), assessing the risks and benefits of treatment, preventing or d
Autor:
June Y. Hou, Jocelyn S. Chapman, Ekaterina Kalashnikova, William Pierson, Karen Smith-McCune, Geovanni Pineda, Reena Marie Vattakalam, Alexandra Ross, Meredith Mills, Carlos J. Suarez, Tracy Davis, Robert Edwards, Michelle Boisen, Sarah Sawyer, Hsin-Ta Wu, Scott Dashner, Vasily N. Aushev, Giby V. George, Meenakshi Malhotra, Bernhard Zimmermann, Himanshu Sethi, Adam C. ElNaggar, Alexey Aleshin, James M. Ford
Publikováno v:
Gynecologic oncology.
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. We examined the utility of circulating tumor DNA (ctDNA) as a prognostic biomarker for EOC by assessing its relationship with patient outcome and CA-125, pre-surgically and du
Autor:
Maggie Zhou, Nam Bui, Richa Rathore, Sumedha Sudhaman, Giby V. George, Allyson K. Malashevich, Meenakshi Malhotra, Minetta C. Liu, Alexey Aleshin, Kristen N. Ganjoo
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 157
Background: Leiomyosarcomas (LMS) are aggressive malignancies with a propensity for early relapse. Current surveillance modalities include physical exam and imaging; however, radiological response to therapy may only manifest after 4–6 cycles of tr
Autor:
Efrat, Dotan, Louise C, Walter, Ilene S, Browner, Katherine, Clifton, Harvey Jay, Cohen, Martine, Extermann, Cary, Gross, Sumati, Gupta, Genevieve, Hollis, Joleen, Hubbard, Reshma, Jagsi, Nancy L, Keating, Elizabeth, Kessler, Thuy, Koll, Beatriz, Korc-Grodzicki, June M, McKoy, Sumi, Misra, Dominic, Moon, Tracey, O'Connor, Cynthia, Owusu, Ashley, Rosko, Marcia, Russell, Mina, Sedrak, Fareeha, Siddiqui, Amy, Stella, Derek L, Stirewalt, Ishwaria M, Subbiah, William P, Tew, Grant R, Williams, Liz, Hollinger, Giby V, George, Hema, Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(9)
The NCCN Guidelines for Older Adult Oncology address specific issues related to the management of cancer in older adults, including screening and comprehensive geriatric assessment (CGA), assessing the risks and benefits of treatment, preventing or d
Autor:
Jason Russell Williams, Kassondra Grzankowski, Kayla Castaneda, Jose Salvador Saldivar, Concepcion Diaz-Arrastia, Georges Azzi, Hemant Sindhu, Young Kwang Chae, Ekaterina Kalashnikova, Brittany Nicosia, Shilpa Tekula, Giby V. George, Meenakshi Malhotra, Adam ElNaggar, Alexey Aleshin
Publikováno v:
Journal of Clinical Oncology. 40:e17501-e17501
e17501 Background: The role of immunotherapy in gynecologic malignancies continues to evolve. Use of immune checkpoint blockade (ICB) agents have consistently demonstrated less than a 15% response rate in ovarian, cervical, and subsets of endometrial
Autor:
Giby V. George, Efrat Dotan, Jeffrey M. Hardacre, Charles M. Vollmer, William G. Hawkins, Kelsey Klute, Timothy R. Donahue, Brian G. Czito, Courtney L. Scaife, Margaret A. Tempero, Beth Lynn, Cristina R. Ferrone, Jorge Obando, E. Gabriela Chiorean, John W. Kunstman, Mokenge P. Malafa, Andrew M. Lowy, Sushanth Reddy, Eric K. Nakakura, Jeanne Shen, Amol Narang, Vincent Chung, Dana Backlund Cardin, Marsha Reyngold, Marco Del Chiaro, Noelle K. LoConte, Mahmoud M. Al-Hawary, Cassadie Moravek, Stephen W. Behrman, Christos Fountzilas, Mary Dillhoff, Brian M. Wolpin, Al B. Benson, Patricio M. Polanco, Andrew H. Ko, Robert A. Wolff
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(4)
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients’ advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provid